Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Then why does jjdc own 24.6% of warren robotics?
Really? ZERO SPECULATION, that is unbelievable that is what u think, ZERO speculation. I can't even begin to imagine what info u look at to have ZERO speculation that jnj/Google are not looking at acquiring. Hmmmm, who should investors believe, an anonymous poster on ihub or Gary pruden/Alex gorsky. I think I will go with experienced executives for $200 Alex.
I have to say this one more time zero speculation, really?
That's wrong look at their job postings. How else do you explain external robotics company.
That is one of the reasons I'm invested in this stock. All my dd and research leads me to believe that Titan will partner w someone who I believe will be warren robotics. I believe in the market for robotics, the tech of Titan, ximedica and fowler.
The only question left for me (and it's the biggest one) is who will warren robotics partner w? I pushed my chips into the middle that it will be Titan.
The only blinder that I might have is that I am missing another robotic company that is viable for warren robotics
But JnJ/Google was mentioned yet neither of them are developing a robotic platform internally - hmmm maybe they will partner with an innovative medtech company that is the late stage of developing an innovative surgical robotic platform like Titan Medical - $TITXF
Do you know what a surgical robotic system is?
I saw from the technicals that TRXC hit the ominous Cliff Dive when it went from $14/share to $2.36/share. For all those on the board that talk about us needing a press release to get PPS up, look at press release today about the robotics market that mentioned trxc and notice TRXC stock went down. Press releases don't mean anything if the product isn't good (i.e. TRXC - again, down from $14/share)
I agree with you Katalyst. As for leaks happening, I totally disagree with that. I'm in healthcare and had no idea of the Medtronic/Covidien merger until it happened, IF there was something that BIG that could be kept under wraps then a deal with Titan can be kept under wraps. I know people that worked at both medtronic and covidien and they didn't see it coming. Leaks for the most part only happen if they want a leak to happen.
Why buy 9k more shares then? Waste of my time reading these posts at this point.
TRXC at $2.30 give or take a couple of pennies, down from a high of $14/share about a year ago.
The IREP technology that Titan uses for SPORT is also designed for microsurgery capabilities. If SPORT can also offer a platform for Microsurgery all I can say is WOW!
http://www.titanmedicalinc.com/titan-medical-inc-enters-into-exclusive-license-agreement-with-columbia-university-for-novel-single-port-robotic-surgery-system/
I'm not going
for L&S, after reading through all the info about Robotics from Gary Pruden, go back to the Titan Presentation and re-read it, it's an amazing coincidence to some of the terminology
http://www.titanmedicalinc.com/wp-content/uploads/2015/05/Titan-Medical-Inc.-AGM-2015-Presentation.pdf
Of note for me: Bottom of Page 15, bottom of page 19, page 31
my understanding is reposable end effectors are used a limited number of times (i.e. 10x) and then discarded. They are not true 1x disposable end effectors. In my understanding of the Titan press release (below) - they want single patient use (1x) and customizable - unique to TItan
http://www.titanmedicalinc.com/titan-medical-inc-signs-agreement-with-worldwide-supplier-of-single-patient-use-robotic-tools/
Correct - Microline is reposable not disposable
You gave to take out the sales of the tooling and the service contracts, the university wouldn't get a piece of that, just the capital sales
I agree but there is something wrong with being consistently negative and uninformed.
Really, you judge them as self-righteous as if they are slinging marijuana stocks. I am amazed at some investors that can't see things develop, i wouldn't be surprised if there is a partnership or M/A with Titan and some investors will still find something to tear it down. At Ramses, Gary Pruden, Andy Conrad adn John Hargrove could all be on stage discussing SPORT and some people would still be doubters and would no doubt want to share those opinions with the board.
I wouldn't waste my time giving the crib notes of the call to people on this board. Those who are invested and L&S will look at the transcript and diligently read thru it. Beside I prefer competing for shares with people that aren't informed, better for investors who do due diligence.
Flybabyfly u were right and actually left out a very important detail concerning that which investors who read thru it and are L&S will see a strong connection to our investment.
really?
anythings possible, some people can't see JnJ/Google or Medtronic or ISRG or whoever but all it takes is one buyer and the right timing.
A M&A could also involve ISRG, it is not impossible to think that they would want Titan IP to strengthen their grip on robotic surgery considering companies like Warren Robotics and Medtronic are entering their space.
Then why would jjdc own 23.6% of warren robotics? Jjdc is bringing the robot. IMO, that is the only explanation for jjdc owning 23.6% of warren robotics. I would be interested in others opinions of why jjdc owns 23.6% of warren robotics.
Also, everything that I researched from the recent advamed conf was jnj discussing "partnership" w innovative medtech companies.
If it is Titan, I could see it starting as a partnership with potential of acquisition down the line.
That principle buyer planning job is new. I don't remember seeing that before. Anyone who is L&S take the time to read thru that posting. When I got they it this was my only thought:
Jnj is definitely buying a robotic surgical platform, is it Titan?
I don't like speculation, know what else I don't like, if the stock of a company was $14 and now down to $2 and change.
If u go on ISRG's website, they have about a 2 1/2 minute video talking about the new daVinci and how it was design,etc. It is pretty well done (professionally) and generates a sense of excitement, I would like Titan to do something like that at Ramses.
everyone has 15 minutes
agree with Jedi, they would not PR anything and if this is big, there is NO WAY they would PR it.
According to the Ramses Agenda, Titan has a segment that is them presenting on SPORT. they are not attendees but rather presenters at Ramses. I would agree with Timesyours on this one, if they show they same thing they did at the AGM then I would be disappointed. I think they will show something differently and eye-opening. October 24, can't wait to see what comes out of that.
Ishrak had told analysts after the close of the merger with Covidien that the new company will look at U.S.-based companies with early-stage technologies to beef up Medtronic's product pipeline.
"So the M&A activity from us, certainly from a technology perspective, is very sort of close to what we’re focusing on. Bigger deals, obviously opportunistically, we’ll look at it, but that’s a matter of our overall financial bandwidth and our management bandwidth," he said during a conference call.
Medtronic bringing in $9.8 Billion into US for M&A possibilities - could make things interesting
Imo, press release is probably announcement of Q4 milestone achievement. While not M&A, still would be great to see them complete that early Q4
Read an article on TRXC on SeekingAlpha that mentioned investors would need to hold their investment for another 5 years to even make a dime on this investment. 5 YEARS! 5 years is 2020, good thing I am invested in TITXF where even the non-believers know it will start making a huge return on TITXF investment in 2 years.
I would agree that the patent info alone is not interesting but for those on this board that have done an intense amount of due diligence, this info along with other "tidbits" continue to help the puzzle picture become clearer. For me it was very interesting information that continues to reinforce my investment in TITXF. Thanks for sharing.
http://www.barchart.com/stocks/vleaders.php
Volume sales per stock - explanation given earlier regarding volume traded does not translate
TRXC volume today leads to drop in PPS - down over 22% in 5 days. I guess volume trades don't lead to increase in PPS or value as has been suggested on this board.
Good thing I didn't invest when they had amadeaus and I am invested in TITXF and SPORT.
At least I didn't invest in surgilube.
Just to point out AGAIN how you are wrong in just the one sentence you posted. You said "Titan is not working with anyone other than Ximedica" BUT they are, they signed an agreement with a end effector supplier and are working with Anne Arundel Medical Center - it is amazing how you can be wrong time after time and you can show it in one sentence.
Except is says "external robotic company"
New job posting one day ago for Electro-Mechanical Engineer - Surgical Robotics at Ethicon
Job description
Listing Info
Electro-Mechanical Engineer - Surgical Robotics-5470150427
Description
Ethicon, a part of the Johnson and Johnson family of companies, is currently recruiting an Electro-Mechanical Engineer for the development of surgical robotic instruments in their Cincinnati, Ohio location.
The Ethicon Surgical Care business offers a broad range of products, platforms and technologies—including sutures, surgical staplers, clip appliers, trocars and synthetic mesh devices—that are used in a wide variety of minimally invasive and open surgical procedures. Specialties include support for treatment of colorectal and thoracic conditions, women’s health conditions, hernias, cancer and obesity. The Ethicon Surgical Care business combines products and services of two market-leading legacy companies, both with long histories of medical innovation. Ethicon, Inc. based in Somerville, New Jersey, was founded more than 80 years ago as a pioneer in suture development and manufacturing, helping to transform the safety and effectiveness of open surgery. Ethicon Endo-Surgery, Inc. was created 20 years ago in Cincinnati, Ohio, developing innovative devices that have driven the revolutionary shift from open to minimally invasive surgery that continues to lead the industry today.
This position is for an Electro-Mechanical Engineer working with internal and external development teams to ensure effective delivery of novel tools for a new surgical robot. The Electro-Mechanical Engineer will collaborate across internal and external organizations to help define, implement, and commercialize novel surgical interfaces tools for a new robotics platform.
Collaborate with internal and external stakeholders to define and co-develop complex electro-mechanical tool / robot interfaces.
Serve as a primary technical interface between internal organizations and external robotics companies and tool suppliers. Ensure full technical communication, alignment, and transparency to facilitate timely commercialization.
Manage technical interface requirements in collaboration with external parties, including future needs for advanced tools, connectivity, and upgrades, as well as other sources of technical requirements such as electrical safety standards
Manage resolution of interface issues, tradeoffs, and risk under direction of overall project team, and ensure appropriate testing / validation of Ethicon and external tools in the robotic environment.
Serve a lead technical role in creating and executing multi-generational tool plans and road maps. May include evaluation of internal or external opportunities to improve system performance, facilitate new procedures, or broaden business unit product line.
J2W:LI NA
Qualifications
A Bachelor’s Degree in an engineering discipline (electrical, mechanical, systems, or related discipline) with 6 years of experience in engineering product development in a highly-regulated environment (e.g. medical devices, aerospace, automotive) is required for this role. A Master’s Degree with a minimum of 4 years of experience is preferred. Demonstrated success in a position working across organizational boundaries, including success in influencing without direct authority, is required for this role. In addition, experience in regulated product development and commercialization with substantial face-to-face customer contact, as well as medical device experience, are highly preferred.
Skills
Experience in the following skills are key to success in this position:
Ability to collaborate and build technical relationships across internal and external boundaries, and to influence without direct authority.
Experience translating high-level customer needs into technical options and analyzing the tradeoffs and business impact
Technical understanding of multi-disciplinary interfaces, potentially including mechanics, electrical, data, software, and surgical energy
Deep understanding of surgery, surgical procedures, and the design and application of surgical devices, as well as the quality system / regulatory environment.
Strong electro-mechanical design and analysis skills, including tools such as Solid Works (CAD), Matlab / Simulink, FMEA’s, and son.
Excellent Communication and collaboration skills